Diabetes Devices Market (Insulin Delivery Devices: Insulin Pumps, Insulin Syringes, Insulin Pens & Insulin Inhalers; Glucose Monitoring Devices: Glucose Test Strips, Lancing Devices and Lancets, Glucose Meters, Continuous Glucose Monitoring) - Growth, Future Prospects and Competitive Analysis, 2016 - 2022

The International Diabetes Foundation (IDF) reports that as of 2013, 382 Mn individuals i.e. 8.3% of the global adult population is living with diabetes, and is expected that over the next 25 years, this population would rise beyond 592 Mn. The IDF also reports that with 175 Mn diabetes cases being currently undiagnosed, a large set of diabetic population is unknowingly heading towards disease related complications, thus adding to the potential yet avoidable disease burden. Additionally, 80% of the total diabetic patient pool lives in middle- and low-income countries, where the prevalence is on a phenomenal growth.

This report on global diabetes devices studies market for devices and equipment used for monitoring and treatment of diabetes. For the purpose of this report, the diabetes devices market is segmented into insulin delivery devices and glucose monitoring devices categories. The insulin delivery devices market is classified as insulin pumps, insulin syringes, insulin pens and insulin inhalers segments. Glucose test strips, lancing devices and lancets, glucose meters and continuous glucose monitors are the glucose monitoring devices studied in this report. This report presents the market size and forecast for each device segment for the period 2014-2022, along with respective CAGRs for the forecast during 2016-2022.

Geographically, the global diabetes market is studied for the following regional markets:

North America

a.    U.S.

b.    Canada


a.    U.K.

b.    Germany

c.    Rest of Europe


a.    Japan

b.    China

c.    Rest of Asia-Pacific

Middle East and Africa

Latin America

The market size and forecast for the period 2014-2022 along with the CAGRs for the period 2016-2022 for the mentioned segments are also presented in this study. Cumulative presentation, market size and forecast of insulin delivery devices and glucose monitoring devices for individual country level markets are also provided in this report.

Qualitative information sets such as market dynamics (drivers, challenges, future prospects) and market inclination insights are provided in this market assessment report. Tools such as competition assessment and attractive investment proposition are also included in this study for studying the global market competition. The report concludes with company profiles section that highlights key information about the major market players operating in the global diabetes devices market. 

Diabetes Devices Market

Based on geographical segmentation, the global diabetes devices market is studied for:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa

Diabetes Devices Market

The global diabetes devices market is currently led by North America and Europe. United States is the largest contributor to the overall market revenue. High disease prevalence, awareness in the patient population and better reimbursement policies majorly contribute to the dominance of these regional markets. Asia-Pacific, Middle East and Africa, and Latin America markets will witness higher growth against that of the global growth. Phenomenal rise in diabetes prevalence in Asia, and other middle- and low-income countries, increasing healthcare expenditure, growing awareness about effective diabetes management are the major drivers of these markets. Some of the prime national markets in these regions are India, China, Russia, Saudi Arabia and others.

Choose License Type
Published Date:  Jun 2016
Category:  Medical Devices
Report ID:   57947
Report Format:   PDF
Pages:   120
Rating:    4.5 (60)
Connect With Us
24/7 Research Support